Current market trends establish a product need. Drug recalls have been steadily increasing since 2014. Products containing undeclared drug ingredients or particulate matter have been the most common reason for recalls since 2009.
InQuest Science Exclusivity
InQuest Science is the only digital defect management solution built by authors of USP 790 and 1790, the standards that govern pharmaceutical visual inspection. That expertise is embedded in the Identifier, which unites particulate and defect data across the entire product lifecycle, from raw materials to finished product, giving quality teams one source of truth in place of scattered spreadsheets and disconnected databases.
Purpose
Our Mission
Distinction
Why Choose Us
Specialized Expertise
One Source of Truth
Faster, Compliant Workflows
Training and Qualification
Regulatory Confidence
Better Batch Decisions
Defect Library and Traceability
Scales With You
Our Team

Anthony Amato
Chief Executive OfficerMr. Amato founded InQuest Science in March of 2017. He founded Amega Scientific Corporation in 1999. He grew the company from a startup operation to a worldwide industry leader.

Roy Cherris
Chief Science OfficerMr. Cherris has over 40 years of Quality Assurance experience and is a founding member and Managing Partner of Bridge Associates International. An author of USP 790 and 1790 and an active member of the USP expert panel, he is one of the industry’s foremost authorities on visual inspection.

Jeff Marino
Chief Technology OfficerMr Marino runs a successful software consultancy, BaSys Tech Services. He began his career in the pharmaceutical industry in 1993 building vision and barcode inspection systems.

Maggie Schwanda
Director of Business OperationsMs. Schwanda was the Director of Business Operations for Amega Scientific Corporation. She was responsible for the groups global business development.

Anthony Amato II
Product Development ManagerMr. Amato is responsible for the organization strategies through the effective direction and management of resources, while being accountable for the business strategies.

Scott Aldrich
Scientific AdvisorMr. Aldrich worked in the pharmaceutical industry for over forty years and was an author of USP 790 and 1790. His expertise centered on the application of materials science methods for the identification of particulate matter.

Michael Winton
AdvisorMr. Winton is a private equity professional and middle market CFO with more than 12 years of finance, investment banking, and corporate strategy experience.
Our Commitment
Behind every injectable drug is a patient who trusts it is safe. InQuest Science exists to help the companies who make those medicines honor that trust, giving quality teams a modern way to detect defects, qualify inspectors, and prove compliance with confidence. Our goal is simple: to set the new standard for particulate and defect data management, so that safer products reach the people who depend on them.